Disease/Infection News

RSS

New carbon nanomaterial fights disease causing bacteria

A new form of paper with the built-in ability to fight disease-causing bacteria could have applications that range from anti-bacterial bandages to food packaging that keeps food fresher longer to shoes that ward off foot odor. A report about the new material, which consists of the thinnest possible sheets of carbon, appears in ACS Nano, a monthly journal.

22 Jul 2010

Fera acquires investigational new drug for treatment of fungal otitis externa

Fera Pharmaceuticals announces the acquisition of an investigational new drug to treat fungal otitis externa (FOE).

22 Jul 2010

Study shows potential impact of syringe type on injection-related HIV epidemics among drug users

Syringe type affects HIV transmission among intravenous drug users, according to a study by researchers at RTI International. The study, published online in Addiction, used a mathematical model to illustrate the potential impact of syringe type on injection-related HIV epidemics in low- and high-risk intravenous drug user populations.

22 Jul 2010

Smoking cessation effectively alter subgingival microbiome in patients on periodontal therapy: Study

Patients with chronic gum disease who quit smoking in addition to undergoing nonsurgical therapy not only demonstrated a lower abundance of harmful oral pathogens, but also an increase in health-associated bacteria. The researchers from The Ohio State University, Columbus Ohio, and Newcastle University, United Kingdom report their findings in the July 2010 issue of the Journal of Clinical Microbiology.

22 Jul 2010

Onconase, Amphinase 2 show positive results for SARS virus: Tamir Biotechnology

Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases confirmed that testing of two (2) of the company's compounds Onconase (Ranpirnase), and recombinant Amphinase 2 showed positive in vitro results for Severe Acute Respiratory Syndrome, also known as (SARS) virus.

22 Jul 2010

Current myths vs. realities in global AIDS funding

Activists at the International AIDS Conference in Vienna are charging developed and developing country governments with writing checques that bounce to the millions of people in need of lifesaving HIV treatment. Despite the gains in treatment numbers reported by WHO, the International Treatment Preparedness Coalition's (ITPC), latest report, Rationing Funds, Risking Lives, documents early warnings of the global pullback on AIDS commitment and funding.

22 Jul 2010

Study marks significant milestone for microbicide research field, HIV prevention

Today we congratulate the Centre for the AIDS Programme of Research in South Africa and the people of South Africa on the positive findings from the CAPRISA 004 microbicide study, which marks a significant milestone both for the microbicide research field and HIV prevention as a whole.

22 Jul 2010

Flat global funding for HIV prevention research could have serious consequences: Report

Following significant advances in vaccine and microbicide research, including results presented today of 39% efficacy in the CAPRISA 004 microbicide gel trial among women in South Africa, a new report released today warns that flat funding for HIV prevention research may limit researchers' ability to quickly move promising approaches forward.

22 Jul 2010

Experts outline three elements necessary for ending HIV/AIDS pandemic

According to a new editorial, the world can control and ultimately end the HIV/AIDS pandemic through a three-pronged strategy

22 Jul 2010

AIDS 2010: Advocates march in Vienna for human rights of HIV/AIDS patients

Thousands of HIV/AIDS advocates, gathered for the International AIDS Conference-AIDS 2010, "marched through Vienna's city centre on Tuesday evening, demanding more respect for human rights in the fight against HIV," Agence France-Presse reports.

22 Jul 2010

AIDS 2010 interviews

Managing editor of the Kaiser Daily Global Health Policy Report, Jill Braden Balderas, interviews global health leaders participating in AIDS 2010.

22 Jul 2010

AIDS 2010 studies, releases: PMTCT, treating children, male circumcision; National prevention programs; IDUs

"In parts of Africa, only about half of babies born to mothers with HIV receive the HIV prevention drug nevirapine," according to a study published Wednesday, HealthDay News/U.S. News & World Report reports.

22 Jul 2010

AIDS 2010 opinions: U.S. AIDS funding; Human rights and HIV; Invest in primary care; Microbicide gel's possibilities

"Having met President [Barack] Obama, I'm confident that he's a man of conscience who shares my commitment to bringing hope and care to the world's poor. But I am saddened by his decision to spend less than he promised to treat AIDS patients in Africa," Desmond Tutu, archbishop emeritus of Cape Town and honorary chairman of the Global AIDS Alliance, writes in a New York Times opinion piece.

22 Jul 2010

CFAR receives a five-year renewal grant to continue AIDS research

The Case Western Reserve University/University Hospitals Case Medical Center Center for AIDS Research announced today it has received a five-year renewal grant from the National Institutes of Health for $9 million. The CFAR provides clinical and technological support to researchers working on HIV-related projects at Case Western Reserve, University Hospital Case Medical Center, MetroHealth Medical Center, Cleveland Clinic, and several international sites.

22 Jul 2010

Today's OpEds: U.S. and AIDS; Mass. example on health reform?; Unions and health costs

George W. Bush made an impressive commitment to the international fight against AIDS when he formed the President's Emergency Plan for AIDS Relief program. … Thanks to these efforts — and similar initiatives ... the number of African patients with access to AIDS drugs jumped tenfold from 2003 to 2008. Since 2004, the AIDS-related mortality rate in sub-Saharan Africa has dropped 18 percent. Yet President Obama added only $366 million to the program this year — well below the $1 billion per year he promised to add when he was on the campaign trail (Desmond Tutu, 7/20).

22 Jul 2010

NIH awards KGI $3.6M grant to develop diagnostic assays and devices for multi-drug resistant tuberculosis

Keck Graduate Institute (KGI) Director of Research Angelika Niemz has been awarded a four-year, $3.6 million collaborative research grant from the National Institutes of Health (NIH).

21 Jul 2010

Shionogi-ViiV Healthcare to advance '572 inhibitor into Phase III clinical trials

Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phase III clinical trials. '572 will be the only once-daily, unboosted integrase inhibitor in Phase III clinical development.

21 Jul 2010

New insights on early pathogenic events, strategies for preventing HIV infection

In a plenary lecture at the 18th International AIDS conference in Vienna, Austria, Anthony S. Fauci, M.D., will present new insights on the early and complex pathogenic events that occur rapidly-within hours to days-following sexual exposure to HIV.

21 Jul 2010

NovaBay reports positive results from NVC-422 Phase 2a proof-of-concept clinical trial for impetigo

NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.

21 Jul 2010

Report: Older gay, bisexual men enrolled in long-term study of HIV used illicit drugs infrequently

Most older gay and bisexual men enrolled in a long-term study of HIV used recreational drugs infrequently over a 10-year period, report University of Pittsburgh Graduate School of Public Health researchers at the XVIII International AIDS Conference.

21 Jul 2010

Disease/Infection News

New carbon nanomaterial fights disease causing bacteria

Fera acquires investigational new drug for treatment of fungal otitis externa

Study shows potential impact of syringe type on injection-related HIV epidemics among drug users

Smoking cessation effectively alter subgingival microbiome in patients on periodontal therapy: Study

Onconase, Amphinase 2 show positive results for SARS virus: Tamir Biotechnology

Current myths vs. realities in global AIDS funding

Study marks significant milestone for microbicide research field, HIV prevention

Flat global funding for HIV prevention research could have serious consequences: Report

Experts outline three elements necessary for ending HIV/AIDS pandemic

AIDS 2010: Advocates march in Vienna for human rights of HIV/AIDS patients

AIDS 2010 interviews

AIDS 2010 studies, releases: PMTCT, treating children, male circumcision; National prevention programs; IDUs

AIDS 2010 opinions: U.S. AIDS funding; Human rights and HIV; Invest in primary care; Microbicide gel's possibilities

CFAR receives a five-year renewal grant to continue AIDS research

Today's OpEds: U.S. and AIDS; Mass. example on health reform?; Unions and health costs

NIH awards KGI $3.6M grant to develop diagnostic assays and devices for multi-drug resistant tuberculosis

Shionogi-ViiV Healthcare to advance '572 inhibitor into Phase III clinical trials

New insights on early pathogenic events, strategies for preventing HIV infection

NovaBay reports positive results from NVC-422 Phase 2a proof-of-concept clinical trial for impetigo

Report: Older gay, bisexual men enrolled in long-term study of HIV used illicit drugs infrequently

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News